Recombinant RSV (Motavizumab Biosimilar) antibody

Catalog No. ABIN7487808

The Mammalian Cells Monoclonal anti-RSV (Motavizumab Biosimilar) antibody is suitable to detect RSV (Motavizumab Biosimilar) in samples from Human. It has been validated for ELISA.

Quick Overview for Recombinant RSV (Motavizumab Biosimilar) antibody (ABIN7487808)

Target: RSV (Motavizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This RSV (Motavizumab Biosimilar) antibody is un-conjugated

Application: ELISA

Grade: Research Grade

Product Details anti-RSV (Motavizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Motavizumab Biosimilar - Anti-RSV mAb

Characteristics: Antibody Type: IgG1-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for RSV (Motavizumab Biosimilar)

Target: RSV (Motavizumab Biosimilar)

Target Type: Biosimilar

Background: MEDI-524
Motavizumab is a humanized monoclonal antibody for the prevention of respiratory syncytial virus infection in high-risk infants.

CAS-No: 677010-34-3